What are Emergent Biosolutions's total assets?

Emergent Biosolutions (EBS) holds $1.3B in total assets, down 7.4% year over year.

How much debt does Emergent Biosolutions have?

Emergent Biosolutions carries $584.6M in total debt against $523.1M of shareholders' equity, a debt-to-equity ratio of 1.12.

How much cash does Emergent Biosolutions have?

Emergent Biosolutions holds $161.5M in cash and equivalents.

Can Emergent Biosolutions cover its short-term obligations?

Its current ratio is 4.29 — current assets exceed current liabilities.

Where does Emergent Biosolutions's balance sheet data come from?

Every line is extracted from Emergent Biosolutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Emergent Biosolutions EBS Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$209.1M+98.0%	$105.6M-5.5%	$111.7M-82.6%	$642.6M+11.5%
Restricted cash	$3.7M-39.3%	$6.1M—	$0—	$0-100%
Accounts receivable, net	$84.2M-45.5%	$154.5M-19.1%	$191M+20.0%	$159.2M-42.9%
Inventories	$343.4M+10.2%	$311.7M-5.2%	$328.9M-6.2%	$350.7M+1.8%
Raw materials	$120.6M+25.8%	$95.9M-25.5%	$128.7M-9.6%	$142.3M-34.6%
Work in process	$109M+26.3%	$86.3M-23.8%	$113.3M-2.5%	$116.2M+21.3%
Finished goods	$113.8M-12.1%	$129.5M+49.0%	$86.9M-5.7%	$92.2M+146%
Prepaid expenses and other current assets	$25.8M-4.1%	$26.9M-43.8%	$47.9M-17.3%	$57.9M-17.5%
Total current assets	$662.5M+10.7%	$598.7M-11.9%	$679.5M-43.9%	$1.21B-4.7%
Property and equipment, net	$205.4M-24.1%	$270.6M-29.3%	$382.8M-53.2%	$817.6M+2.2%
Accumulated depreciation	$304.1M-23.4%	$397.1M-3.5%	$411.4M+7.2%	$383.8M+20.3%
Operating lease right-of-use assets	6.5%+1.0%	5.5%+0.2%	5.3%+1.2%	4.1%0.0%
Intangible assets, net	$436.5M-13.0%	$501.5M-11.5%	$566.6M-22.3%	$728.8M+20.5%
Other non-current assets	$6.4M-66.1%	$18.9M-90.3%	$194.3M+1.6%	$191.3M+229%
Total assets	$1.32B-5.1%	$1.39B-23.8%	$1.82B-42.4%	$3.17B+7.1%
Accounts payable	$55.6M-8.7%	$60.9M-45.7%	$112.2M+8.4%	$103.5M-19.7%
Accrued expenses	$41.8M-25.5%	$56.1M-24.3%	$74.1M-15.1%	$87.3M-1.6%
Deferred revenue	$5M+4.2%	$4.8M-82.4%	$27.2M+3.0%	$26.4M+126%
Operating lease liabilities, current	$2.4M-11.1%	$2.7M-22.9%	$3.5M-39.7%	$5.8M0.0%
Contract liabilities	$14.4M+54.8%	$9.3M-68.9%	$29.9M-5.7%	$31.7M+93.3%
Income taxes payable	$6.8M+17.2%	$5.8M—	——	——
Total current liabilities	$132.2M-18.6%	$162.4M-75.1%	$651.3M-47.0%	$1.23B+229%
Long-term debt	$572.1M-13.8%	$663.7M+48.6%	$446.5M-0.4%	$448.5M-44.6%
Operating lease liabilities, non-current	$9.2M-5.2%	$9.7M-29.7%	$13.8M-6.8%	$14.8M-38.8%
Operating Lease Liabilities (Total)	$11.6M-6.5%	$12.4M-28.3%	$17.3M-16.0%	$20.6M-31.3%
Other non-current liabilities	$53.9M+37.9%	$39.1M+35.3%	$28.9M-30.4%	$41.5M-40.3%
Total liabilities	$21.7M+34.0%	$16.2M+189%	$5.6M-30.0%	$8M-81.5%
Preferred stock	$0—	$0—	$0—	$0—
Common stock	200M+199,900%	100K0.0%	100K0.0%	100K0.0%
Additional paid-in capital	$942.4M+1.6%	$928M+2.6%	$904.4M+3.5%	$873.5M+5.3%
Retained earnings	-$159.8M+24.8%	-$212.4M-874%	-$21.8M-103%	$738.7M-22.3%
Accumulated other comprehensive income (loss)	-$7.5M-44.2%	-$5.2M+8.8%	-$5.7M-284%	$3.1M+119%
Treasury stock	$252.6M+10.9%	$227.7M0.0%	$227.7M0.0%	$227.7M+49.6%
Total stockholders' equity	$522.6M+8.2%	$482.8M-25.6%	$649.3M-53.2%	$1.39B-13.9%
Total liabilities and stockholders' equity	$1.32B-5.1%	$1.39B-23.8%	$1.82B-42.4%	$3.17B+7.1%
Allowance for Doubtful Accounts	$800K+60.0%	$500K-77.3%	$2.2M+214%	$700K-78.1%
Allowance for Doubtful Accounts Receivable (Current)	$800K+60.0%	$500K-77.3%	$2.2M+214%	$700K-78.1%
Finished goods	$113.8M-12.1%	$129.5M+49.0%	$86.9M-5.7%	$92.2M+146%
Materials and supplies	$120.6M+25.8%	$95.9M-25.5%	$128.7M-9.6%	$142.3M-34.6%
Contract Assets, Non-Current	$6.4M-34.0%	$9.7M-55.7%	$21.9M-37.1%	$34.8M+61.9%
Deferred Tax Assets and Other Non-Current Assets	$14.2M-24.9%	$18.9M-90.3%	$194.3M+1.6%	$191.3M+229%
Finite Lived Intangible Assets - Gross	$855.4M0.0%	$855.4M-3.8%	$889.5M-12.5%	$1.02B+26.5%
Net Investment in Lease	$10.6M-9.4%	$11.7M-27.8%	$16.2M-16.5%	$19.4M-31.4%
Intangible assets — net	$436.5M-13.0%	$501.5M-11.5%	$566.6M-22.3%	$728.8M+20.5%
Other intangible assets—net	$436.5M-13.0%	$501.5M-11.5%	$566.6M-22.3%	$728.8M+20.5%
Operating lease right-of-use assets	$10.6M-9.4%	$11.7M-27.8%	$16.2M-16.5%	$19.4M-31.4%
Other non-current assets	$14.2M-24.9%	$18.9M-90.3%	$194.3M+1.6%	$191.3M+229%
Property, plant and equipment at cost	$509.5M-23.7%	$667.7M-15.9%	$794.2M-33.9%	$1.2B+7.3%
Operating Lease Right-of-Use Assets in Other Assets	$10.6M-9.4%	$11.7M-27.8%	$16.2M-16.5%	$19.4M-31.4%
Software and Technology Licenses, Net	$14.2M-24.9%	$18.9M-90.3%	$194.3M+1.6%	$191.3M+229%
Accrued Manufacturing Costs	$41.8M-25.5%	$56.1M-24.3%	$74.1M-15.1%	$87.3M-1.6%
Other Commercial Liabilities	$12.2M-31.1%	$17.7M-4.8%	$18.6M-46.7%	$34.9M-32.5%
Accrued Income Taxes, Current	$6.8M+17.2%	$5.8M—	——	——
Accrued Liabilities, Current	$12.2M-31.1%	$17.7M-4.8%	$18.6M-46.7%	$34.9M-32.5%
Compensation and benefits	$41.8M-25.5%	$56.1M-24.3%	$74.1M-15.1%	$87.3M-1.6%
Other accrued liabilities	$10.8M-50.7%	$21.9M-33.0%	$32.7M-28.8%	$45.9M-37.2%
Total debt	$583.7M-13.7%	$676.1M-23.0%	$877.5M-38.5%	$1.43B+63.8%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	60.9M+1.7%	59.9M+3.6%	57.8M+3.8%	55.7M+1.1%
Convertible Preferred Stock Authorized Shares	15M0.0%	15M0.0%	15M0.0%	15M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$100K0.0%	$100K0.0%	$100K0.0%	$100K0.0%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Warrants and Rights Outstanding	——	——	——	——
Cumulative Cost Basis	$509.5M-23.7%	$667.7M-15.9%	$794.2M-33.9%	$1.2B+7.3%
Accounts Receivable, Allowance for Credit Loss	$800K+60.0%	$500K-77.3%	$2.2M+214%	$700K-78.1%
Contingent liabilities	$0—	——	——	——
Retentions held by customers	$66.8M-50.7%	$135.4M-4.5%	$141.8M+38.1%	$102.7M-54.3%
Class of Warrant or Right, Outstanding	——	——	——	——
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$200M0.0%	$200M0.0%	$200M0.0%	$200M0.0%
Common stock, shares issued (in shares)	$60.9M+1.7%	$59.9M+3.6%	$57.8M+3.8%	$55.7M+1.1%
Common Stock, Shares, Outstanding	$52.1M-4.1%	$54.3M+4.0%	$52.2M+4.2%	$50.1M-2.3%
Contract with Customer, Liability	$14.4M+54.8%	$9.3M-68.9%	$29.9M-5.7%	$31.7M+93.3%
Deferred Finance Costs Noncurrent Net	$17.6M-51.5%	$36.3M+343%	$8.2M+2.5%	$8M-5.9%
Deferred income taxes	$37.8M-9.4%	$41.7M-11.7%	$47.2M-20.9%	$59.7M-36.0%
Finite-Lived Intangible Assets, Accumulated Amortization	$418.9M+18.4%	$353.9M+9.6%	$322.9M+12.4%	$287.4M+44.5%
Gross Carrying Amount	$855.4M0.0%	$855.4M-3.8%	$889.5M-12.5%	$1.02B+26.5%
Operating Lease Weighted Average Discount Rate Percent	$0.07+18.2%	$0.06+3.8%	$0.05+29.3%	$0.040.0%
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$15M0.0%	$15M0.0%	$15M0.0%	$15M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied	——	——	——	——
Accrued excise taxes	——	——	——	——
Treasury stock, shares (in shares)	$8.7M+55.4%	$5.6M0.0%	$5.6M0.0%	$5.6M—
Unbilled balances	$18.2M-7.1%	$19.6M-61.9%	$51.4M-10.1%	$57.2M+14.9%
Warrant liability	$21.7M+34.0%	$16.2M—	$0—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Emergent Biosolutions.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Emergent Biosolutions's total assets?: Emergent Biosolutions (EBS) holds $1.3B in total assets, down 7.4% year over year.
How much debt does Emergent Biosolutions have?: Emergent Biosolutions carries $584.6M in total debt against $523.1M of shareholders' equity, a debt-to-equity ratio of 1.12.
How much cash does Emergent Biosolutions have?: Emergent Biosolutions holds $161.5M in cash and equivalents.
Can Emergent Biosolutions cover its short-term obligations?: Its current ratio is 4.29 — current assets exceed current liabilities.
Where does Emergent Biosolutions's balance sheet data come from?: Every line is extracted from Emergent Biosolutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.